L26/P-900 Outcomes of uterine heterotopic pregnancies after in vitro fertilisation–embryo transfer
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Y. Ouyang und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Study question How do uterine ectopic pregnancies (UEPs) impact concomitant intrauterine pregnancies (IUPs) following in vitro fertilisation–embryo transfer (IVF-ET)? Summary answer Outcomes of patients with uterine heterotopic pregnancies (UHPs) are worse than those of patients with ectopic pregnancies (EPs) alone. What is known already In patients with uterine heterotopic pregnancies (UHPs), concomitant EPs can occur in any location outside the uterine cavity, both within and beyond the confines of the uterus. The 2020 ESHRE recommendations first introduced the concept of UEPs. UEPs tend to present initially with mild clinical symptoms, and they often involve a live embryo or foetus. Accurate pretreatment information about the pregnancy location can aid in selecting proper treatment methods and minimises EP risk. Study design, size, duration This retrospective matched cohort study included 59 IVF-ET patients with singleton eutopic pregnancies and concomitant UEPs (UHPs) between June 2006 and December 2022. For each woman with a UHP, 4 control women who met the predefined criteria were randomly selected without replacement. Patients were matched for maternal age (±1 year), infertility type, time of the first ultrasound scan (±2 days after transfer) and insemination method. Participants/materials, setting, methods Women with singleton eutopic pregnancies and concomitant UEPs were selected as the study group. The control group consisted of women with eutopic pregnancies. The pregnancy outcomes of women with UHPs were analysed according to different treatment methods and UEPs implantation locations. Main results and the role of chance UEPs were associated with increased risks of early miscarriage (OR (95% CI: 4.81 (2.60, 8.97); P < 0.001), late miscarriage (OR (95% CI): 4.11 (1.11, 15.3); P = 0.03), preterm birth (OR (95% CI): 11.9 (3.84, 38.0); P < 0.001), very preterm birth (OR (95% CI): 25.0 (3.05, 517); P = 0.006), caesarean section (OR (95% CI): 10.8 (2.19, 195); P = 0.021) and low birth weight (OR (95% CI): 11.9 (3.77, 39.5); P < 0.001), and a significantly lower live birth rate (OR (95% CI): 0.17 (0.09, 0.32); P < 0.001). For patient receiving expectant management, UEPs were associated with increased risks of preterm birth (OR (95% CI): 8.81 (1.95, 47.1); P = 0.006) and low birth weight (OR (95% CI): 11.0 (2.18, 81.7); P = 0.006). For surgical treatment, UEPs were associated with increased risks of early miscarriage (OR (95% CI): 15.5 (6.50, 40.9); P < 0.001), preterm birth (OR (95% CI): 25.8 (3.81, 188); P < 0.001), and low birth weight (OR (95% CI): 25.8 (3.81, 188); P < 0.001) and a decreased live birth rate (OR (95% CI): 0.05 (0.02, 0.13); P < 0.001). Except for the differences in the live birth rates (44.7% vs. 15.4% vs. 75.0% for caesarean scar, cervical and intramural pregnancies, respectively; P = 0.033), the other pregnancy outcomes were similar among UEPs in different implantation locations. Limitations, reasons for caution The sample size was objectively small. Details on obstetric complications were limited. Further analyses of different surgical methods and UEP risk factors are needed. Three embryos were transferred in some patients, which should be avoided as much as possible in the future. Wider implications of the findings This study provides information for the clinical understanding and diagnosis of this rare condition. The results can be used to counsel women with UEPs and help guide appropriate treatment. Trial registration number No
Zitieren
APA
Ouyang, Y., Xihong, L., & Mingxiang, Z. (2026). L26/P-900 Outcomes of uterine heterotopic pregnancies after in vitro fertilisation–embryo transfer. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1224
Vancouver
Ouyang Y, Xihong L, Mingxiang Z. L26/P-900 Outcomes of uterine heterotopic pregnancies after in vitro fertilisation–embryo transfer. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1224
BibTeX
@article{Ouyang2026,
author = {Ouyang, Y. and Xihong, L. and Mingxiang, Z.},
title = {L26/P-900 Outcomes of uterine heterotopic pregnancies after in vitro fertilisation–embryo transfer},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1224}
}
EUVIMED